MAPK7 and cancer: Using genetic and pharmacological inhibition of the MEKK3-MEK5-ERK5 pathway, we observed mitochondrial content increase in human cancer cells, mouse embryonic fibroblasts, and primary erythroid progenitor cells isolated from the murine fetal liver.